The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Lipid and polymer nanoparticles for drug delivery to bacterial biofilms
Open accessAbstract
Biofilms are matrix-enclosed communities of bacteria that show increased antibiotic resistance and the capability to evade the immune system. They can cause recalcitrant infections which cannot be cured with classical antibiotic therapy. Drug delivery by lipid or polymer nanoparticles is considered a promising strategy for overcoming biofilm resistance. These particles are able to improve the delivery of antibiotics to the bacterial cells, thereby increasing the efficacy of the treatment. In this review we give an overview of the types of polymer and lipid nanoparticles that have been developed for this purpose. The antimicrobial activity of nanoparticle encapsulated antibiotics compared to the activity of the free antibiotic is discussed in detail. In addition, targeting and triggered drug release strategies to further improve the antimicrobial activity are reviewed. Finally, ample attention is given to advanced microscopy methods that shed light on the behavior of nanoparticles inside biofilms, allowing further optimization of the nanoformulations. Lipid and polymer nanoparticles were found to increase the antimicrobial efficacy in many cases. Strategies such as the use of fusogenic liposomes, targeting of the nanoparticles and triggered release of the antimicrobial agent ensured the delivery of the antimicrobial agent in close proximity of the bacterial cells, maximizing the exposure of the biofilm to the antimicrobial agent. The majority of the discussed papers still present data on the in vitro anti-biofilm activity of nanoformulations, indicating that there is an urgent need for more in vivo studies in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R., & Lappin-Scott, H. M. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.003431 · Cited by 4,544
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Biofilms as Complex Differentiated Communities
Stoodley, P., Sauer, K., Davies, D. G., & Costerton, J. W. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160705 · Cited by 3,158
Chitosan as antimicrobial agent: applications and mode of action.
Rabea, E. I., Badawy, M. E.-T., Stevens, C. V., Smagghe, G., & Steurbaut, W. (2003) · Biomacromolecules · doi:10.1021/bm034130m · Cited by 3,123
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Survival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
SINGLE-PARTICLE TRACKING:Applications to Membrane Dynamics
Saxton, M. J., & Jacobson, K. (1997) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.26.1.373 · Cited by 1,810
The Lectins: Carbohydrate-Binding Proteins of Plants and Animals
Goldstein, I. J., & Hayes, C. E. (1978) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(08)60220-6 · Cited by 1,621
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Costerton, J. W., Geesey, G. G., & Cheng, K.-J. (1978) · Scientific American · doi:10.1038/scientificamerican0178-86 · Cited by 1,441
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Stewart, P. S. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.5.1485-1491.2003 · Cited by 1,178
Evolving concepts in biofilm infections
Hall-Stoodley, L., & Stoodley, P. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01323.x · Cited by 1,136
How bacteria talk to each other: regulation of gene expression by quorum sensing
Bassler, B. L. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00025-9 · Cited by 1,026
Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Nickel, J. C., Ruseska, I., Wright, J. B., & Costerton, J. W. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.4.619 · Cited by 889
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804
Look who's talking: communication and quorum sensing in the bacterial world
Williams, P., Winzer, K., Chan, W. C., & Cámara, M. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2039 · Cited by 799
Bjarnsholt, T., Alhede, M., Alhede, M., Eickhardt-Sørensen, S. R., Moser, C., Kühl, M., Jensen, P. Ø., & Høiby, N. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.002 · Cited by 764
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
Hadinoto, K., Sundaresan, A., & Cheow, W. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.002 · Cited by 702
The Challenge of Treating Biofilm-associated Bacterial Infections
del Pozo, J. L., & Patel, R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100247 · Cited by 671
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425 · cited 1×
“[15 , 17, 19 ‐ 21] There is an urgent need for innovative strategies that are able to overcome these mechanisms of resistance.”
Diffusion of Nanoparticles in a Biofilm
Peulen, T.-O., & Wilkinson, K. J. (2011) · Environmental Science & Technology · doi:10.1021/es103450g · Cited by 419
Liposomes as delivery systems for antibiotics
Drulis-Kawa, Z., & Dorotkiewicz-Jach, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.033 · Cited by 356
Meers, P., Neville, M., Malinin, V., Scotto, A. W., Sardaryan, G., Kurumunda, R., Mackinson, C., James, G., Fisher, S., & Perkins, W. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn059 · Cited by 345
Bagge, N., Schuster, M., Hentzer, M., Ciofu, O., Givskov, M., Greenberg, E. P., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1175-1187.2004 · Cited by 345
Jefferson, K. K., Goldmann, D. A., & Pier, G. B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2467-2473.2005 · Cited by 319
Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles
Cheow, W. S., & Hadinoto, K. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.033 · Cited by 297
Ungaro, F., d'Angelo, I., Coletta, C., d'Emmanuele di Villa Bianca, R., Sorrentino, R., Perfetto, B., Tufano, M. A., Miro, A., La Rotonda, M. I., & Quaglia, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.010 · Cited by 297
Strathmann, M., Wingender, J., & Flemming, H.-C. (2002) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(02)00032-5 · Cited by 282
Lipid-Based Nanoparticles for siRNA Delivery in Cancer Therapy: Paradigms and Challenges
Gomes-da-Silva, L. C., Fonseca, N. A., Moura, V., Pedroso de Lima, M. C., Simões, S., & Moreira, J. N. (2012) · Accounts of Chemical Research · doi:10.1021/ar300048p · Cited by 254
Antimicrobial Effect of Chitosan Nanoparticles on Streptococcus mutans Biofilms
Chávez de Paz, L. E., Resin, A., Howard, K. A., Sutherland, D. S., & Wejse, P. L. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02941-10 · Cited by 245
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
Clancy, J. P., Dupont, L., Konstan, M. W., Billings, J., Fustik, S., Goss, C. H., Lymp, J., Minic, P., Quittner, A. L., Rubenstein, R. C., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202230 · Cited by 222
Biofilms: microbes and disease
Aparna, M. S., & Yadav, S. (2008) · Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702008000600016 · Cited by 216
Lessons in Fluctuation Correlation Spectroscopy
Digman, M. A., & Gratton, E. (2011) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-032210-103424 · Cited by 214
Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery
Raemdonck, K., Braeckmans, K., Demeester, J., & De Smedt, S. C. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60299k · Cited by 188
Self-citationRani, S. A., Pitts, B., & Stewart, P. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.728-732.2005 · Cited by 185
Cevc, G. (1991) · Biochemistry · doi:10.1021/bi00243a021 · Cited by 173
Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms
Jensen, E. T., Kharazmi, A., Lam, K., Costerton, J. W., & Høiby, N. (1990) · Infection and Immunity · doi:10.1128/iai.58.7.2383-2385.1990 · Cited by 173
Mugabe, C., Halwani, M., Azghani, A. O., Lafrenie, R. M., & Omri, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01547-05 · Cited by 169
Biofilms, Infection, and Antimicrobial Therapy
(2005) · CRC Press eBooks · doi:10.1201/9781420028232 · Cited by 165
Scott, C., Abdelghany, Quinn, Ingram, Gilmore, Donnelly, & Taggart (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34341 · Cited by 161
Alipour, M., Suntres, Z. E., & Omri, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp165 · Cited by 161
Healthcare Epidemiology: Quorum Sensing: Bacteria Talk Sense
Sifri, C. D. (2008) · Clinical Infectious Diseases · doi:10.1086/592072 · Cited by 161
Iannitelli, A., Grande, R., Stefano, A. D., Giulio, M. D., Sozio, P., Bessa, L. J., Laserra, S., Paolini, C., Protasi, F., & Cellini, L. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12085039 · Cited by 160
Interaction of positively-charged liposomes with blood: implications for their application in vivo
Senior, J. H., Trimble, K. R., & Maskiewicz, R. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90160-a · Cited by 157
Trigger release liposome systems: local and remote controlled delivery?
Bibi, S., Lattmann, E., Mohammed, A. R., & Perrie, Y. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.646330 · Cited by 151
Nicolosi, D., Scalia, M., Nicolosi, V. M., & Pignatello, R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.01.015 · Cited by 145
Sachetelli, S., Khalil, H., Chen, T., Beaulac, C., Sénéchal, S., & Lagacé, J. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00217-5 · Cited by 140
Halwani, M., Yebio, B., Suntres, Z. E., Alipour, M., Azghani, A. O., & Omri, A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn422 · Cited by 140
Alhajlan, M. M. A., Alhariri, M., & Omri, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00235-13 · Cited by 129
Beaulac, C., Clement-Major, S., Hawari, J. A.-A., & Lagacé, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.665 · Cited by 128
Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents
Chakraborty, S. P., Sahu, S. K., Mahapatra, S. K., Santra, S., Bal, M., Roy, S., & Pramanik, P. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/10/105103 · Cited by 122
Macromolecular mechanisms of sputum inhibition of tobramycin activity
Hunt, B. E., Weber, A., Berger, A., Ramsey, B. W., & Smith, A. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.34 · Cited by 120
Forier, K., Messiaen, A.-S., Raemdonck, K., Deschout, H. G., Rejman, J., Baets, F. D., Nelis, H. J. C. F., Smedt, S. C. D., Demeester, J., Coenye, T., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.129 · Cited by 119
Self-citationChakraborty, S. P., Sahu, S. K., Pramanik, P., & Roy, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.033 · Cited by 115
Mugabe, C., Azghani, A. O., & Omri, A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh518 · Cited by 113
Jones, M. N., Song, Y.-H., Kaszuba, M., & Reboiras, M. D. (1997) · Journal of drug targeting · doi:10.3109/10611869708995855 · Cited by 108
Guiot, E., Georges, P., Brun, A., Fontaine‐Aupart, M., Bellon‐Fontaine, M., & Briandet, R. (2002) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2002)0750570hodimb2.0.co2 · Cited by 102
Beaulac, C., Sachetelli, S., & Lagacé, J. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.1.35 · Cited by 98
Diffusion of Nanoparticles in Biofilms Is Altered by Bacterial Cell Wall Hydrophobicity
Habimana, O., Steenkeste, K., Fontaine‐Aupart, M., Bellon‐Fontaine, M., Kulakauskas, S., & Briandet, R. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02163-10 · Cited by 94
Transport of Nanoparticles and Tobramycin-loaded Liposomes in Burkholderia cepacia Complex Biofilms
Messiaen, A., Forier, K., Nelis, H., Braeckmans, K., & Coenye, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079220 · Cited by 92
Self-citationCheow, W. S., Chang, M. W., & Hadinoto, K. (2011) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2011.08.035 · Cited by 90
Li, C., Zhang, X., Xinliang, Xiaoying, Guojian, & Chen, Z. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41695 · Cited by 89
Cheow, W. S., & Hadinoto, K. (2010) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2010.08.050 · Cited by 89
Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa
Hadinoto, K., & Cheow, W. S. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.02.032 · Cited by 85
Mugabe, C., Azghani, A. O., & Omri, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.005 · Cited by 84
Cytolytic activity of liposomes containing stearylamine
Yoshihara, E., & Nakae, T. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90068-4 · Cited by 79
Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia
Halwani, M., Mugabe, C., Azghani, A. O., Lafrenie, R. M., Kumar, A., & Omri, A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm289 · Cited by 78
Alipour, M., Suntres, Z. E., Lafrenie, R. M., & Omri, A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq036 · Cited by 78
Reactive liposomes encapsulating a glucose oxidase-peroxidase system with antibacterial activity
Hill, K. J., Kaszuba, M., Creeth, J. E., & Jones, M. N. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00007-2 · Cited by 73
Drulis‐Kawa, Z., Dorotkiewicz‐Jach, A., Gubernator, J., Guła, G., Bocer, T., & Doroszkiewicz, W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.043 · Cited by 72
Cheow, W. S., & Hadinoto, K. (2012) · Particuology · doi:10.1016/j.partic.2011.08.007 · Cited by 72
Cheow, W. S., Chang, M. W., & Hadinoto, K. (2010) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2010.1116 · Cited by 67
The adsorption of cationic liposomes to Staphylococcus aureus biofilms
Kim, H., Gias, E., & Jones, M. N. (1999) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(98)00765-1 · Cited by 67
Alipour, M., Suntres, Z. E., Halwani, M., Azghani, A. O., & Omri, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005724 · Cited by 62
In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains
Drulis‐Kawa, Z., Gubernator, J., Dorotkiewicz‐Jach, A., Doroszkiewicz, W., & Kozubek, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.017 · Cited by 62
Enhanced liposome-mediated activity of piperacillin against staphylococci
Nacucchio, M. C., Bellora, M. J., Sordelli, D. O., & D'Aquino, M. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.1.137 · Cited by 61
In Vitro Fusion of Reticulocyte Endocytic Vesicles with Liposomes
Vidal, M., & Hoekstra, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17823 · Cited by 61
Sanderson, N. M., Guo, B., Jacob, A. E., Handley, P. S., Cunniffe, J. G., & Jones, M. N. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00099-5 · Cited by 57
Yamakami, K., Tsumori, H., Sakurai, Y., Shimizu, Y., Nagatoshi, K., & Sonomoto, K. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.717227 · Cited by 56
Alhariri, M., & Omri, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01634-12 · Cited by 53
The specificity and affinity of immunoliposome targeting to oral bacteria
Robinson, A. M., Creeth, J. E., & Jones, M. N. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00231-9 · Cited by 49
Nguyen, S., Hiorth, M., Rykke, M., & Smistad, G. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.004 · Cited by 48
The targeting of phospholipid liposomes to bacteria
Jones, M. N., Kaszuba, M., Reboiras, M. D., et al. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90295-x · Cited by 48
Diffusion of Macromolecules in Model Oral Biofilms
Takenaka, S., Pitts, B., Trivedi, H. M., & Stewart, P. S. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02279-08 · Cited by 48
Treatment of osteomyelitis by liposomal gentamicin-impregnated calcium sulfate
Hui, T., Xu, Y., Tiane, Z., Li, G., You, Y., Muyao, J., Li, J., & Ding, J. (2008) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-008-0782-8 · Cited by 46
Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin
Halwani, M., Blomme, S., Suntres, Z. E., Alipour, M., Azghani, A. O., Kumar, A., & Omri, A. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.008 · Cited by 44
Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes
Jones, M. N., Francis, S., Hutchinson, F. J., et al. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90010-w · Cited by 44
THE APPLICATION OF CONFOCAL MICROSCOPY TO THE STUDY OF LIPOSOME ADSORPTION ONTO BACTERIAL BIOFILMS
Ahmed, K., Gribbon, P. M., & Jones, M. N. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120016195 · Cited by 43
Tooth-Binding Micelles for Dental Caries Prevention
Chen, F., Liu, X.-M., Rice, K. C., Li, X., Yu, F., Reinhardt, R. A., Bayles, K. W., & Wang, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-09 · Cited by 43
Ma, T., Bei-cheng, S., Tang, H., Zhou, T., Xu, G., Hong-liang, L., Chen, Q., & Xu, Y. (2011) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/092050611x570644 · Cited by 40
Liposome combined porous β-TCP scaffold: Preparation, characterization, and anti-biofilm activity
Zhu, C., Xu, Y., Shi, J., Li, J., & Ding, J. (2010) · Drug Delivery · doi:10.3109/10717541003762870 · Cited by 39
Vyas, S. P., Sihorkar, V., & Dubey, P. K. (2001) · PubMed · Cited by 36
Solute Size Effects on the Diffusion in Biofilms of Streptococcus mutans
Marcotte, L., Therien-Aubin, H., Sandt, C., Barbeau, J., & Lafleur, M. (2004) · Biofouling · doi:10.1080/08927010400010494 · Cited by 35
Liu, X.-M., Zhang, Y., Chen, F., Khutsishvili, I., Fehringer, E. V., Marky, L. A., Bayles, K. W., & Wang, D. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0812-7 · Cited by 33
Marier, J., Lavigne, J. R., & Ducharme, M. P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3776-3781.2002 · Cited by 33
Polyhydroxy-mediated interactions between liposomes and bacterial biofilms
Jones, M. N., & Kaszuba, M. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90331-x · Cited by 30
Fang, Y., Lou, M.-M., Li, B., Xie, G., Wang, F., Li, Z., & Luo, Y.-C. (2009) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-009-0187-z · Cited by 30
Zhou, T., Su, M., Bei-cheng, S., Ma, T., Xu, G., Li, H., Chen, Q., Sun, W., & Xu, Y. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.648196 · Cited by 28
Nanoparticle Deposition onto Biofilms
Miller, J. K., Neubig, R. D., Clemons, C. B., Kreider, K. L., Wilber, J. P., Young, G. W., Ditto, A. J., Yun, Y., Milsted, A., Badawy, H. T., et al. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0626-0 · Cited by 25
The Use of Phospholipid Liposomes for Targeting to Oral and Skin-Associated Bacteria
Jones, M. N., Kaszuba, M., Hill, K. J., Song, Y.-H., & Creeth, J. E. (1994) · Journal of drug targeting · doi:10.3109/10611869408996813 · Cited by 23
Günday-Türeli, N., Türeli, A. E., & Schneider, M. (2014) · Drug Delivery Letters · doi:10.2174/2210303104666140222002101 · Cited by 12
Role of Sterol Δ5(6)Desaturase in Azole Antifungal Mode of Action and Resistance
Lamb, D. C., Kelly, D. E., Corran, A. J., Baldwin, B. C., & Kelly, S. L. (1996) · Pesticide Science · doi:10.1002/(sici)1096-9063(199603)46:3<255::aid-ps345>3.0.co;2-y · Cited by 2
Cited by
Targeting microbial biofilms: current and prospective therapeutic strategies
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P., & Hall-Stoodley, L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.99 · Cited by 1,800
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
Makabenta, J. M. V., Nabawy, A., Li, C.-H., Schmidt-Malan, S., Patel, R., & Rotello, V. M. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0420-1 · Cited by 1,397
Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control
Liu, Y., Shi, L., Su, L., van der Mei, H. C., Jutte, P. C., Ren, Y., & Busscher, H. J. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00807d · Cited by 737
Nanoparticle–Biofilm Interactions: The Role of the EPS Matrix
Fulaz, S., Vitale, S., Quinn, L., & Casey, E. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.07.004 · Cited by 562
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Metadata
- Authors
- Forier, K., Raemdonck, K., De Smedt, S. C., Demeester, J., Coenye, T., & Braeckmans, K.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 190
- Pages
- 607-623
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1998624315
- Cited by
- 464
- References
- 108
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.